A Prospective,Randomized Study of the Comparative Safety and Efficacy of Intraperitoneal Imipenem versus Vancomycin and Netilmicin in the Treatment of Peritonitis on CAPD
Restricted accessResearch articleFirst published online April, 1995
A Prospective,Randomized Study of the Comparative Safety and Efficacy of Intraperitoneal Imipenem versus Vancomycin and Netilmicin in the Treatment of Peritonitis on CAPD
GokalR., BogIeS., HuntL.CAPD peritonitis still a major problem in CAPD: results of a multicentre study.J Nephrol1989; 2: 95–9.
2.
Report of the Working Party BSAC.Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis.Lancet1987; 1: 845–9.
3.
The Ad Hoc Advisory Committee on peritonitis management.Continuous ambulatory peritoneal dialysis (CAPD): treatment recommendations: 1989 update.Perit Dial Int1989; 9: 247–56.
4.
The Ad Hoc Advisory Committee on peritonitis management.Peritoneal dialysis related peritonitis treatment recommendations: 1993 update.Perit Dial Int1993; 13: 14–28.
5.
VasS.I.Microbiological aspects of chronic ambulatory dialysis.Kidney Int1983; 23: 83–92.
6.
WereA.J., MarsdenA., ToothA., RamsdenR.T., GokalR.Netilmicin and vancomycin in the treatment of peritonitis in patients on CAPD.Clin Nephrol1992; 32: 209–13.
7.
GruerL.D., TurneyJ.H., CurleyJ., MichaelJ., AduD.Vancomycin and tobramycin in the treatment of CAPD peritonitis.Nephron1985; 41: 279–82.
8.
KahanF.M., KroppH., Sundel ofJ.G., BirnbaumJ.Thienamycin: development of imipenem/cilastatin.Antimicrob Agents Chemother1983; 12(Suppl D): 1–35.
9.
MistryC.D., SalgiaP., ManosJ.Netilmicin and vancomycin in the treatment of peritonitis in patients on CAPD. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in continuous ambulatory peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1986: 129–33.
10.
AhlmenJ., BronnestamR., ErikssonC., TorgesenA.K., CarlssonL.Imipenem in the treatment of peritonitis during CAPD.Nephrol Dial Transplant1991; 20(4): 498500, 515.
11.
LuiS.G., ChengA.F.B., LeungC.B.Imipenem/cilastatin sodium in the treatment of CAPD-associated peritonitis.Am J Nephrol1994; 14: 182–186.
12.
MerchantM., AnwarN., WereA., UttleyL., ToothA., GokalR.Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1992; 234–7.
13.
CalandraG., LydickE., CarriganJ., WeissL., GuessH.Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.Am J Med1988; 84: 911–18.
14.
CalandraG., BrownK.R., GradL.C., AkonkhaiV.I., WangC., AzizM.A.Review of adverse experiences and tolerability in the first 2, 516 patients treated with imipenem/ cilastatin.Am J Med1985; 78(Suppl 6A): 73–8.
